Therapeutic Use Exemptions: When a Banned Medicine Is Allowed

A prescription and permission are different things

A doctor may lawfully prescribe a medicine that appears on WADA’s Prohibited List. That prescription treats the medical condition, but it does not by itself settle the athlete’s anti-doping status.

The TUE process supplies that second decision. It permits specified therapeutic use within sport’s anti-doping system.

Four conditions must all be satisfied

The International Standard requires medical necessity: without the prohibited treatment, the athlete would suffer a significant impairment of health. The treatment must not be expected to enhance performance beyond a return to normal health.

There must be no reasonable permitted therapeutic alternative, and the need cannot be wholly or partly the consequence of earlier non-therapeutic prohibited use. These are cumulative tests, not options.

An independent committee reviews the evidence

The responsible anti-doping organisation establishes a Therapeutic Use Exemption Committee of physicians. The application normally includes diagnosis, clinical history, examination findings and an explanation of alternatives.

The committee, not the athlete’s treating doctor alone, decides whether the anti-doping standard is met. This separation protects both medical care and consistent competition rules.

Athletes should normally apply in advance

An athlete who knows a prohibited treatment is required should apply before using it or competing, subject to the standard’s timing rules. A TUE specifies substance or method, dose, route, frequency and duration.

Retroactive approval is limited to defined circumstances, including emergencies and situations where advance application was not reasonably possible. It is not a general cure for forgetting to apply.

Recognition matters when competition level changes

A national anti-doping organisation may grant a TUE that an international federation must then recognise for international competition. The standard sets a process for recognition, review and appeal.

That institutional layer resembles how doping bans work: jurisdiction and procedure matter alongside the laboratory or medical fact.

A TUE is not a secret licence to enhance

The permission is narrow and medically defined. Exceeding the approved terms can leave the athlete exposed to an anti-doping violation.

Medical files are protected by confidentiality rules, which is why outsiders rarely possess enough evidence to judge an individual case. The athlete biological passport and whereabouts system are separate tools; none substitutes for the TUE decision.